These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25622891)

  • 21. Recent developments in adenosine receptor ligands and their potential as novel drugs.
    Müller CE; Jacobson KA
    Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of caffeine on behavioral and inflammatory changes elicited by copper in zebrafish larvae: Role of adenosine receptors.
    Cruz FF; Leite CE; Kist LW; de Oliveira GM; Bogo MR; Bonan CD; Campos MM; Morrone FB
    Comp Biochem Physiol C Toxicol Pharmacol; 2017 Apr; 194():28-36. PubMed ID: 28163255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists.
    Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R
    Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine receptor ligands: where are we, and where are we going?
    Tuccinardi T; Martinelli A
    Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944
    [No Abstract]   [Full Text] [Related]  

  • 25. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
    Piersen CE; True CD; Wells JN
    Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors.
    Jespers W; Oliveira A; Prieto-Díaz R; Majellaro M; Åqvist J; Sotelo E; Gutiérrez-de-Terán H
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29125553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.
    IJzerman AP; van der Wenden EM; van Galen PJ; Jacobson KA
    Eur J Pharmacol; 1994 Jun; 268(1):95-104. PubMed ID: 7925617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation.
    Grant MB; Davis MI; Caballero S; Feoktistov I; Biaggioni I; Belardinelli L
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2068-73. PubMed ID: 11481274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure based prediction of subtype-selectivity for adenosine receptor antagonists.
    Katritch V; Kufareva I; Abagyan R
    Neuropharmacology; 2011 Jan; 60(1):108-15. PubMed ID: 20637786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The surmountable effect of FSCPX, an irreversible A(1) adenosine receptor antagonist, on the negative inotropic action of A(1) adenosine receptor full agonists in isolated guinea pig left atria.
    Gesztelyi R; Kiss Z; Wachal Z; Juhasz B; Bombicz M; Csepanyi E; Pak K; Zsuga J; Papp C; Galajda Z; Branzaniuc K; Porszasz R; Szentmiklosi AJ; Tosaki A
    Arch Pharm Res; 2013 Mar; 36(3):293-305. PubMed ID: 23456693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic activity at adenosine A1 receptors: partial and inverse agonism.
    de Ligt RA; IJzerman AP
    Curr Pharm Des; 2002; 8(26):2333-44. PubMed ID: 12369948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structure of the adenosine receptors: implications for drug discovery.
    Lane JR; Jaakola VP; Ijzerman AP
    Adv Pharmacol; 2011; 61():1-40. PubMed ID: 21586354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling.
    Moro S; Deflorian F; Spalluto G; Pastorin G; Cacciari B; Kim SK; Jacobson KA
    Chem Commun (Camb); 2003 Dec; (24):2949-56. PubMed ID: 14703805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
    Geldenhuys WJ; Hanif A; Yun J; Nayeem MA
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28587166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine receptors as therapeutic targets.
    Jacobson KA; Gao ZG
    Nat Rev Drug Discov; 2006 Mar; 5(3):247-64. PubMed ID: 16518376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats.
    Poleszak E; Malec D
    Pol J Pharmacol; 2003; 55(3):319-26. PubMed ID: 14506310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine receptor subtypes: characterization and therapeutic regulation.
    Olah ME; Stiles GL
    Annu Rev Pharmacol Toxicol; 1995; 35():581-606. PubMed ID: 7598508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzothiazinones: a novel class of adenosine receptor antagonists structurally unrelated to xanthine and adenine derivatives.
    Gütschow M; Schlenk M; Gäb J; Paskaleva M; Alnouri MW; Scolari S; Iqbal J; Müller CE
    J Med Chem; 2012 Apr; 55(7):3331-41. PubMed ID: 22409573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.
    Vernall AJ; Stoddart LA; Briddon SJ; Ng HW; Laughton CA; Doughty SW; Hill SJ; Kellam B
    Org Biomol Chem; 2013 Sep; 11(34):5673-82. PubMed ID: 23881285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms.
    Haskó G; Kuhel DG; Chen JF; Schwarzschild MA; Deitch EA; Mabley JG; Marton A; Szabó C
    FASEB J; 2000 Oct; 14(13):2065-74. PubMed ID: 11023991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.